The nation of Zimbabwe has rejected a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' request for confidential biological samples.
This move became public following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
A government representative has since clarified that the United States was seeking biological samples for research and commercial purposes while refused to share the benefits from any future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more talks to secure a agreement agreeable to all parties so the country's critical HIV programme can continue.
Broader Context
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a high court blocked a related health funding agreement following legal challenges were raised about the security of citizens' health data.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and accountability.
According to statements, Sixteen African countries have so far agreed to similar health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," he stated.
"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the end products would be available to our citizens if a new pandemic arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting frameworks already set up via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This framework is designed to ensure that when a nation contributes its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued discussions with our American counterparts on how subsequent co-operation might be designed in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that negotiations should continue given that much of the nation's Aids initiatives depended on international support.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it said.
The situation emphasises the ongoing debate between receiving much-needed international aid and protecting a country's data in an ever more data-driven world.